There was considerably significant difference in cancer immunity cycle (Fig. 7D), indicating a connection between the tumor immune microenvironment and the risk score, suggesting that TEX may influence the prognosis of HNSCC by modulating the immune cycle state. Here, TEX46 is linked to head and neck squamous cell carcinoma.